Our observations of increased SNX4 levels in the brains of young APP/PS1 mice and decreased SNX4 levels in the brains of old APP/PS1 mice and patients with late-stage AD prompted us to investigate the role of SNX4 by overexpression and knockdown. Here, APP is linked to Alzheimer disease.